Ocugen to Participate in Upcoming October Investor and Industry Conferences
Key Highlights
- ➤Ocugen (OCGN) executives will present at two October investor and industry conferences
- ➤H.C. Wainwright panel scheduled October 1, 2026, in Munich, Germany
- ➤Cell & Gene Meeting on the Mesa panel scheduled October 6, 2026, in Phoenix, AZ
Expert Statements
Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen
“Structured Finance Solutions: Royalty, Credit and Other Alternative Financing Options for Life Sciences”
Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen
“Navigating the Road to Approval, Commercialization, and the Future of Cell and Gene Therapy”
MALVERN, Pa., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology company developing gene therapies for blindness diseases, today announced that members of its executive leadership team will present at two upcoming investor and industry conferences.
H.C. Wainwright: Biotech on Tap 2026 Location: EY Auditorium, Munich, Germany Date: Thursday, October 1, 2026 Time: 1:45–2:30 p.m. CEST Format: Panel discussion Title: Structured Finance Solutions: Royalty, Credit and Other Alternative Financing Options for Life Sciences Presenter: Session Moderator — Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder, Ocugen
Get started
Create a free account to read the full story.